Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating vision testing in patients with partial seizures treated with Lyrica (pregabalin) or placebo; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsies, Partial | Phase 4 | Status: COMPLETED | Results posted: 2021-02-21